205 related articles for article (PubMed ID: 9276448)
1. Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium.
Blondel O; Vandecasteele G; Gastineau M; Leclerc S; Dahmoune Y; Langlois M; Fischmeister R
FEBS Lett; 1997 Aug; 412(3):465-74. PubMed ID: 9276448
[TBL] [Abstract][Full Text] [Related]
2. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
3. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a human serotonin 5-HT4 receptor cDNA.
Van den Wyngaert I; Gommeren W; Verhasselt P; Jurzak M; Leysen J; Luyten W; Bender E
J Neurochem; 1997 Nov; 69(5):1810-9. PubMed ID: 9349523
[TBL] [Abstract][Full Text] [Related]
6. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
Ouadid H; Seguin J; Dumuis A; Bockaert J; Nargeot J
Mol Pharmacol; 1992 Feb; 41(2):346-51. PubMed ID: 1311410
[TBL] [Abstract][Full Text] [Related]
7. A 5-HT4-like receptor in human right atrium.
Kaumann AJ; Sanders L; Brown AM; Murray KJ; Brown MJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):150-9. PubMed ID: 1658664
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.
Medhurst AD; Kaumann AJ
Br J Pharmacol; 1993 Nov; 110(3):1023-30. PubMed ID: 8298790
[TBL] [Abstract][Full Text] [Related]
9. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium.
Läer S; Remmers F; Scholz H; Stein B; Müller FU; Neumann J
Br J Pharmacol; 1998 Mar; 123(6):1182-8. PubMed ID: 9559903
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
Contesse V; Hamel C; Lefebvre H; Dumuis A; Vaudry H; Delarue C
Mol Pharmacol; 1996 Mar; 49(3):481-93. PubMed ID: 8643088
[TBL] [Abstract][Full Text] [Related]
11. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
[TBL] [Abstract][Full Text] [Related]
12. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.
Krobert KA; Brattelid T; Levy FO; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870
[TBL] [Abstract][Full Text] [Related]
13. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins.
Pindon A; van Hecke G; van Gompel P; Lesage AS; Leysen JE; Jurzak M
Mol Pharmacol; 2002 Jan; 61(1):85-96. PubMed ID: 11752209
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium.
Gergs U; Neumann J; Simm A; Silber RE; Remmers FO; Läer S
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):349-59. PubMed ID: 19002436
[TBL] [Abstract][Full Text] [Related]
16. Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.
McLean PG; Coupar IM
Br J Pharmacol; 1996 Jun; 118(4):1058-64. PubMed ID: 8799582
[TBL] [Abstract][Full Text] [Related]
17. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
Ge J; Barnes NM
Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.
Gerald C; Adham N; Kao HT; Olsen MA; Laz TM; Schechter LE; Bard JA; Vaysse PJ; Hartig PR; Branchek TA
EMBO J; 1995 Jun; 14(12):2806-15. PubMed ID: 7796807
[TBL] [Abstract][Full Text] [Related]
20. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
Brattelid T; Kvingedal AM; Krobert KA; Andressen KW; Bach T; Hystad ME; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):616-28. PubMed ID: 15118808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
